世界の医療用画像ソフトウェア市場2021年-2026年

■ 英語タイトル:Medical Imaging Software Market - Global Outlook and Forecast 2021-2026

調査会社Arizton Advisory & Intelligence社が発行したリサーチレポート(データ管理コード:ARZT21MY008)■ 発行会社/調査会社:Arizton Advisory & Intelligence
■ 商品コード:ARZT21MY008
■ 発行日:2021年5月
■ 調査対象地域:グローバル
■ 産業分野:ソフトウェア
■ ページ数:448
■ レポート言語:英語
■ レポート形式:PDF
■ 納品方式:Eメール
■ 販売価格オプション(消費税別)
Single UserUSD3,750 ⇒換算¥555,000見積依頼/購入/質問フォーム
5 UserUSD4,250 ⇒換算¥629,000見積依頼/購入/質問フォーム
Corporate UserUSD5,250 ⇒換算¥777,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行・送付致します。(請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能)
Arizton Advisory & Intelligence社の概要及び新刊レポートはこちらでご確認いただけます。

★グローバルリサーチ資料[世界の医療用画像ソフトウェア市場2021年-2026年]についてメールでお問い合わせはこちら
*** レポート概要(サマリー)***

本書では、世界の医療用画像ソフトウェア市場を調査対象とし、調査手法、調査目的、調査プロセス、範囲、仮定・注意、市場概要、イントロダクション、市場機会・動向、市場成長要因、市場阻害要因、市場状況、ソフトウェア種類別(医療用画像解析ソフトウェア、医療用画像処理ソフトウェア、医療用画像管理ソフトウェア、その他)分析、モダリティ別(超音波、ラジオグラフィー、コンピューター断層撮影、磁気共鳴画像法、マンモグラフィ)分析、用途別(心臓病、整形手術、腫瘍、神経、消化器病)分析、画像種類別(2D、3D、その他)分析、地域別分析、競争状況、主要企業情報、その他企業など、以下の構成でまとめております。
・調査手法
・調査目的
・調査プロセス
・範囲
・仮定・注意
・市場概要
・イントロダクション
・市場機会・動向
・市場成長要因
・市場阻害要因
・市場状況
・世界の医療用画像ソフトウェア市場規模:ソフトウェア種類別(医療用画像解析ソフトウェア、医療用画像処理ソフトウェア、医療用画像管理ソフトウェア、その他)
・世界の医療用画像ソフトウェア市場規模:モダリティ別(超音波、ラジオグラフィー、コンピューター断層撮影、磁気共鳴画像法、マンモグラフィ)
・世界の医療用画像ソフトウェア市場規模:用途別(心臓病、整形手術、腫瘍、神経、消化器病)
・世界の医療用画像ソフトウェア市場規模:画像種類別(2D、3D、その他)
・世界の医療用画像ソフトウェア市場規模:地域別
・競争状況
・主要企業情報
・その他企業

MEDICAL IMAGING SOFTWARE INDUSTRY INSIGHTS
The global medical imaging software market size was valued at USD 5.8 billion in 2021 and is expected to reach USD 9 billion in 2026, growing at a CAGR of 7% during 2020-2026. Advances in imaging systems and analysis software that help reduce exposure and imaging duration are likely to influence the market. The global medical imaging software market has been significantly affected by the COVID-19 pandemic. Since the outbreak, significant changes have been observed in clinical operations of radiology departments across the world. Amid the COVID-19 flurry, the volume of ambulatory imaging declined dramatically, whereas elective imaging services were shut down. The pandemic affected the usage of software applied in imaging and diagnostics equipment. With the decrease in patients’ volume, the demand for diagnosis and imaging for software development has slow down. Companies developing such software halted their projects due to the decreased demand in COVID-19. A significant decline in the volume of tests such as X-ray, CT, Ultrasound, and MRI was observed in most countries. This sector was deeply affected compared to diagnostics due to the higher prices of medical imaging tests. However, these effects are short-lived, which are unlikely to hamper the long-term growth of the market. The market is to grow at an impressive growth due to high demand for diagnostic imaging software and the introduction of advanced medical imaging equipment.
SNIPPETS
• The global medical image analysis software market size is expected to grow at a CAGR of approx. 8% during 2020–2026 due to rapid and constant progress in computerized medical image visualization.
• The medical image management software segment is likely to grow at the fastest CAGR during the forecast period because of the increased digitalization of medical records and information.
• The ultrasound segment expects to observe a revenue share of over USD 2 billion by 2026 due to rapid innovations in ultrasound technology.
• CT scanners are likely to exhibit revenue growth of over USD 1.6 billion by 2026 due to increased preference for minimally invasive diagnostic procedures.
• Increasing hospitalization rates and rapid advances in medical imaging equipment are majorly contributing to the global medical imaging software market’s growth.
• Orthopedic and neurology segments are expected to grow at a CAGRs of 8% during 2020–2026.
• North America and APAC expect to dominate the market in terms of revenue and growth, respectively, during the forecast period.
GLOBAL MEDICAL IMAGING SOFTWARE MARKET SEGMENTATION
This research report includes a detailed segmentation by
• Type
• Modality
• Application
• Imaging Type
• End-user
• Geography
INSIGHTS BY TYPE
Medical image analysis software is likely to reach over USD 4 billion by 2026. In 2020, the analysis software segment accounted for over 44%, mainly due to the increased demand for analyzing software. Medical imaging has grown into one of the fastest developing areas in the healthcare sector. Over the past few decades, multiple technologies, including CT, MRI, ultrasound, and nuclear imaging, have evolved. Several software types have been developed to handle images and advances in medical image hardware and devices.
The medical image processing software accounted for 25% of the market share in 2020. Image processing methods help store and handle medical data and provide access to radiologists and physicians worldwide, thereby increasing the demand for processing software. Moreover, the increasing sophistication of cross-sectional imaging with rapid development and integration of interventional radiology into the clinical arena has dramatically impacted patient care.
INSIGHTS BY MODALITY
The global ultrasound medical imaging software market is expected to reach over USD 2 billion by 2026, growing at a CAGR of approximately 6%. In 2020, the segment accounted for the market share of approximately 27%. The use of 3D technology in diagnostic radiology could develop better images and high-quality results, thereby influencing the market’s growth. The emergence of breast ultrasound has simplified imaging of women with dense breasts, thereby missing out on cancer detection. Advances in ultrasound technology have increased its attractiveness for several clinical applications, ranging from breast health to cardiology due to non-invasive, cost-effectiveness, and reduced radiation exposure.
Computerized Tomography (CT) is likely to witness the highest incremental growth of over USD 662 million during the forecast period. It is also expected to grow at the fastest CAGR of 9% during 2020–2026. There have been several notable advances in CT technology that are likely to have a significant clinical impact. The increasing elderly population, the growing application of minimally invasive diagnostic procedures, improved healthcare infrastructure in emerging economies are expected to aid the market’s growth.
INSIGHTS BY APPLICATION
The global cardiology medical imaging software market expects to grow at a CAGR of approx.7% during 2020–2026 and accounted for a share of over 22% in 2020. The increasing trend in cardiovascular diagnostics toward non-invasive multimodalities is a significant impetus for the market’s growth. Advances in imaging protocols help reduce radiation exposure, decrease procedural complications, and offer cost-effective algorithms to diagnose obstructive, flow-limiting coronary artery lesions as an adjunct to invasive coronary angiography.
In 2020, the orthopedics segment accounted for over 19% of the global medical imaging software market share. The introduction of advanced 3D digital technological advancements is modernizing orthopedic clinical practices as they allow complex structures to be manufactured in less duration. Such technologies can make complex surgeries precise, cost-effective, and error-free, which is increasing their application. Orthopedic imaging is leveraging an array of image-guided tools such as PACS and MRI to improve diagnosis, planning, execution, and navigation via surgeries.
INSIGHTS BY IMAGING TYPE
Two-dimensional (2D) accounted for the share of over 71% in the global market in 2020. Despite the advance in 3D technology, the market share of 2D techniques is likely to grow as they continue to be applied widely due to the low cost and high resolution. The increasing disease burden across the world is likely to increase the demand for several diagnostic tools. It is estimated that over 3 billion X-ray examinations and more than 25 million echocardiograms are performed annually throughout the world. These statistics depict the high usage of 2D incorporated imaging techniques, leading to the highest contribution to 2D equipment. The 2D market is likely to extend its reach with the inclusion of artificial intelligence and digital technology.
The 3D medical imaging market expects to cross over USD 2 billion by 2026, and the segment accounted for approximately 22% of the market share in 2020. 3D technology is observing high adoption as they assist surgeons to perform invasive procedures and decrease the damage to the surrounding healthy tissues. It offers an innovative opportunity to represent medical data than traditional technologies more accurately.
INSIGHTS BY END-USER
Hospitals accounted for the highest share of 43% of the global medical imaging software market in 2020. Hospital imaging has generated a substantial quantity of revenue and captured a large proportion of the outpatient radiology volume. Other centers displayed a significant decrease in average weekly imaging volume (64%) compared to hospital settings (54%) during the COVID-19 pandemic. The increased demand for digital imaging systems is likely to replace traditional diagnostic systems in hospitals.
Diagnostic centers expect to grow at the fastest CAGR of 8%, registering an absolute growth of over 55% during the forecast period. Diagnostic imaging volumes have been shifting toward independent diagnostic testing facilities. The rise in deductible health plans and recent price transparency regulations helps accelerate the trend toward low-cost settings such as diagnostic centers. The success of non-hospital-based imaging centers could be partly due to the ability to provide expedited and convenient outpatient access.
INSIGHTS BY GEOGRAPHY
North America is likely to account for over USD 3 billion by 2026, growing at a CAGR of approx. 6% during 2020–2026. The rise in the number of hospitals and diagnostic centers has increased the adoption of imaging devices. In the US alone, there are over 10,000 diagnostic centers equipped with imaging and diagnostic systems. Ramping up the availability of portable or mobile imaging systems during the COVID-19 pandemic has helped increase options to diagnose patients inside and outside the healthcare settings. Hence, the major factors contributing to the market’s growth include increasing hospitalization rates demanding high usage medical imaging systems, a large number of imaging centers, and increased demand for diagnostic and imaging systems during the COVID-19 pandemic.
APAC expects to grow at the fastest CAGR of approx. 10% during the forecast period. It is likely to show productive growth due to the growing awareness and high adoption of imaging and diagnostics software by healthcare professionals. China, India, Japan, South Korea, and Australia are the region’s major contributing countries. The market is expected to witness high growth during the forecast period due to rapid growth in the elderly population and prevalence of related disorders, which require early computer aided diagnosis, thereby increasing the need for medical imaging equipment.
COMPETITIVE LANDSCAPE
The global medical imaging software market is observing radial transformations. The incorporation of AI in medical imaging has grown at a higher level in recent years. IBM/Merge, Philips, Agfa, and Siemens have already started integrating AI into their medical imaging software systems. GE showed predictive analytics software using elements of AI for the impact on imaging departments. Philips uses AI as a component of its new Illumeo Software with adaptive intelligence, which automatically pulls in related prior exams for radiology. IBM Watson, Siemens Healthineers, GE Healthcare, Agfa Healthcare, Carestream Health, Cerner Corporation, Change Healthcare, Koninklijke Philips, N.V, Fujifilm Corporation, Sectra AB, and Intelerad Medical Systems are the major market players contributing to the market’s growth.
The global medical imaging software market research report includes in-depth coverage of the industry analysis with revenue and forecast insights for the following segments:
Type
• Medical Image Analysis Software
• Medical Image Processing Software
• Medical Image Management Software
• Others
Modality
• Ultrasound
• Radiography
• Computerized Tomography
• Magnetic Resonance Imaging
• Mammography
• Positron Emission Tomography/ Single Photon Emission Computed Tomography
• Others
Application
• Cardiology
• Orthopedic
• Oncology
• Neurology
• Gastroenterology
• Dental
• Obstetrics and Gynecology
• Others
Imaging Type
• 2D Image
• 3D Image
• Others
End-user
• Hospitals
• Diagnostic Centers
• Ambulatory Surgical Centers (ASCs)
• Research & Academic Institutes
Geography
• North America
• US
• Canada
• Europe
• UK
• Germany
• France
• Italy
• Spain
• APAC
• China
• India
• Japan
• South Korea
• Australia
• Latin America
• Mexico
• Brazil
• Argentina
• Middle East & Africa
• Saudi Arabia
• Turkey
• South Africa

*** レポート目次(コンテンツ)***

1 Research Methodology
2 Research Objectives
3 Research Process

4 Scope & Coverage
4.1 Market Definition
4.1.1 Inclusions
4.1.2 Exclusions
4.2 Base Year
4.3 Scope of The Study
4.4 Market Segmentation
4.4.1 Market Segmentation by Type
4.4.2 Market Segmentation by Modality
4.4.3 Market Segmentation by Application
4.4.4 Market Segmentation by Imaging Type
4.4.5 Market Segmentation by End-user
4.4.6 Market Segmentation by Geography

5 Report Assumptions & Caveats
5.1 Key Caveats
5.2 Currency Conversion
5.3 Market Derivation

6 Market at a Glance
7 Introduction
7.1 Overview

8 Market Opportunities & Trends
8.1 Developments in AI & Cloud-Based Imaging Software Solutions
8.2 Rising Adoption of Digital Breast Tomosynthesis
8.3 Technological Advancements In Medical Imaging Systems

9 Market Growth Enablers
9.1 Growth of Advanced Visualization Technologies
9.2 Rising Demand for Hybrid Imaging Technology
9.3 Quality & Faster Image Acquisition With Optimal Radiation Exposure
9.4 Rising Investments in AI-Based Medical Imaging

10 Market Restraints
10.1 Concerns Of Data Breach & Software Hacking
10.2 Stringent Regulations Slowing Adoption Of AI
10.3 High Cost Of Imaging Equipment & Lack Of Skilled Professionals

11 Market Landscape
11.1 Market Overview
11.2 Market Size & Forecast
11.3 Impact Of COVID-19
11.4 Five Forces Analysis
11.4.1 Threat Of New Entrants
11.4.2 Bargaining Power Of Suppliers
11.4.3 Bargaining Power Of Buyers
11.4.4 Threat Of Substitutes
11.4.5 Competitive Rivalry

12 Software Type
12.1 Market Snapshot & Growth Engine
12.2 Market Overview
12.3 Medical Image Analysis Software
12.3.1 Market Overview
12.3.2 Market Size & Forecast
12.3.3 Medical Image Analysis Software: Geographical Segmentation
12.4 Medical Image Processing Software
12.4.1 Market Overview
12.4.2 Market Size & Forecast
12.4.3 Medical Image Processing Software: Geographical Segmentation
12.5 Medical Image Management Software
12.5.1 Market Overview
12.5.2 Market Size & Forecast
12.5.3 Medical Image Management Software: Geographical Segmentation
12.6 Others
12.6.1 Market Overview
12.6.2 Market Size & Forecast
12.6.3 Others: Geographical Segmentation

13 Modality
13.1 Market Snapshot & Growth Engine
13.2 Market Overview
13.3 Ultrasound
13.3.1 Market Overview
13.3.2 Market Size & Forecast
13.3.3 Ultrasound: Geographical Segmentation
13.4 Radiography
13.4.1 Market Overview
13.4.2 Market Size & Forecast
13.4.3 Radiography: Geographical Segmentation
13.5 Computerized Tomography
13.5.1 Market Overview
13.5.2 Market Size & Forecast
13.5.3 Computerized Tomography: Geographical Segmentation
13.6 Magnetic Resonance Imaging
13.6.1 Market Overview
13.6.2 Market Size & Forecast
13.6.3 Magnetic Resonance Imaging: Geographical Segmentation
13.7 Mammography
13.7.1 Market Overview
13.7.2 Market Size & Forecast
13.7.3 Mammography: Geographical Segmentation
13.8 PET/ SPECT
13.8.1 Market Overview
13.8.2 Market Size & Forecast
13.8.3 PET/SPECT: Geographical Segmentation
13.9 Others
13.9.1 Market Overview
13.9.2 Market Size & Forecast
13.9.3 Others: Geographical Segmentation

14 Application
14.1 Market Snapshot & Growth Engine
14.2 Market Overview
14.3 Cardiology
14.3.1 Market Overview
14.3.2 Market Size & Forecast
14.3.3 Cardiology: Geographical Segmentation
14.4 Orthopedic
14.4.1 Market Overview
14.4.2 Market Size & Forecast
14.4.3 Orthopedic: Geographical Segmentation
14.5 Oncology
14.5.1 Market Overview
14.5.2 Market Size & Forecast
14.5.3 Oncology: Geographical Segmentation
14.6 Neurology
14.6.1 Market Overview
14.6.2 Market Size & Forecast
14.6.3 Neurology: Geographical Segmentation
14.7 Gastroenterology
14.7.1 Market Overview
14.7.2 Market Size & Forecast
14.7.3 Gastroenterology: Geographical Segmentation
14.8 Dental
14.8.1 Market Overview
14.8.2 Market Size & Forecast
14.8.3 Dental: Geographical Segmentation
14.9 Obstetrics & Gynecology
14.9.1 Market Overview
14.9.2 Market Size & Forecast
14.9.3 Obstetrics & Gynecology: Geographical Segmentation
14.10 Others
14.10.1 Market Overview
14.10.2 Market Size & Forecast
14.10.3 Others: Geographical Segmentation

15 Imaging Type
15.1 Market Snapshot & Growth Engine
15.2 Market Overview
15.3 2D
15.3.1 Market Overview
15.3.2 Market Size & Forecast
15.3.3 2D: Geographical Segmentation
15.4 3D
15.4.1 Market Overview
15.4.2 Market Size & Forecast
15.4.3 3D: Geographical Segmentation
15.5 Others
15.5.1 Market Overview
15.5.2 Market Size & Forecast
15.5.3 Others: Geographical Segmentation

16 End-User
16.1 Market Snapshot & Growth Engine
16.2 Market Overview
16.3 Hospitals
16.3.1 Market Overview
16.3.2 Market Size & Forecast
16.3.3 Hospitals: Geographical Segmentation
16.4 Diagnostic Centers
16.4.1 Market Overview
16.4.2 Market Size & Forecast
16.4.3 Diagnostic Centers: Geographical Segmentation
16.5 Ambulatory Surgical Centers
16.5.1 Market Overview
16.5.2 Market Size & Forecast
16.5.3 Ambulatory Surgical Centers: Geographical Segmentation
16.6 Research & Academic Institutes
16.6.1 Market Overview
16.6.2 Market Size & Forecast
16.6.3 Research & Academic Institutes: Geographical Segmentation

17 Geography
17.1 Market Snapshot & Growth Engine
17.2 Geographic Overview

18 North America
18.1 Market Overview
18.2 Market Size & Forecast
18.2.1 North America: Type
18.2.2 North America: Modality
18.2.3 North America: Application
18.2.4 North America: Imaging Type
18.2.5 North America: End-user
18.3 KEY COUNTRIES
18.3.1 US: Market Size & Forecast
18.3.2 Canada: Market Size & Forecast

19 Europe
19.1 Market Overview
19.2 Market Size & Forecast
19.2.1 Europe: Type
19.2.2 Europe: Modality
19.2.3 Europe: Application
19.2.4 Europe: Imaging Type
19.2.5 Europe: End-user
19.3 Key Countries
19.3.1 Germany: Market Size & Forecast
19.3.2 France: Market Size & Forecast
19.3.3 UK: Market Size & Forecast
19.3.4 Italy: Market Size & Forecast
19.3.5 Spain: Market Size & Forecast

20 APAC
20.1 Market Overview
20.2 Market Size & Forecast
20.2.1 APAC: Type
20.2.2 APAC: Modality
20.2.3 APAC: Application
20.2.4 APAC: Imaging Type
20.2.5 APAC: End-user
20.3 Key Countries
20.3.1 China: Market Size & Forecast
20.3.2 Japan: Market Size & Forecast
20.3.3 India: Market Size & Forecast
20.3.4 Australia: Market Size & Forecast
20.3.5 South Korea: Market Size & Forecast

21 Latin America
21.1 Market Overview
21.2 Market Size & Forecast
21.2.1 Latin America: Type
21.2.2 Latin America: Modality
21.2.3 Latin America: Application
21.2.4 Latin America: Imaging Type
21.2.5 Latin America: End-user
21.3 Key Countries
21.3.1 Brazil: Market Size & Forecast
21.3.2 Mexico: Market Size & Forecast
21.3.3 Argentina: Market Size & Forecast

22 Middle East & Africa
22.1 Market Overview
22.2 Market Size & Forecast
22.2.1 Middle East & Africa: Type
22.2.2 Middle East & Africa: Modality
22.2.3 Middle East & Africa: Application
22.2.4 Middle East & Africa: Imaging Type
22.2.5 Middle East & Africa: End-user
22.3 Key Countries
22.3.1 South Africa: Market Size & Forecast
22.3.2 Saudi Arabia: Market Size & Forecast
22.3.3 Turkey: Market Size & Forecast

23 Competitive Landscape
23.1 Competition Overview
23.2 Market Share Analysis
23.2.1 IBM Watson
23.2.2 Siemens Healthineers
23.2.3 GE Healthcare
23.2.4 Agfa Healthcare
23.2.5 Carestream Health
23.2.6 Cerner Corporation
23.2.7 Change Healthcare
23.2.8 Koninklijke Philips
23.2.9 Fujifilm Corporation
23.2.10 Sectra AB
23.2.11 Intelerad Medical Systems

24 Key Company Profiles
24.1 IBM Watson
24.1.1 Business Overview
24.1.2 IBM Watson in Medical Imaging & Diagnostics Software Market
24.1.3 Product Offerings
24.1.4 Key Strategies
24.1.5 Key Strengths
24.1.6 Key Opportunities
24.2 Siemens Healthineers
24.2.1 Business Overview
24.2.2 Siemens Healthineers in Medical Imaging & Diagnostics Software Market
24.2.3 Product Offerings
24.2.4 Key Strategies
24.2.5 Key Strengths
24.2.6 Key Opportunities
24.3 GE Healthcare
24.3.1 Business Overview
24.3.2 GE Healthcare in Medical Imaging & Diagnostics Software Market
24.3.3 Product Offerings
24.3.4 Key Strategies
24.3.5 Key Strengths
24.3.6 Key Opportunities
24.4 Agfa HealthCare
24.4.1 Business Overview
24.4.2 Agfa Healthcare in Medical Imaging & Diagnostics Software Market
24.4.3 Product Offerings
24.4.4 Key Strategies
24.4.5 Key Strengths
24.4.6 Key Opportunities
24.5 Carestream Health
24.5.1 Business Overview
24.5.2 Carestream Health in Medical Imaging & Diagnostics Software Market
24.5.3 Product Offerings
24.5.4 Key Strategies
24.5.5 Key Strengths
24.5.6 Key Opportunities
24.6 Cerner Corporation
24.6.1 Business Overview
24.6.2 Cerner Corporation in Medical Imaging & Diagnostics Software Market
24.6.3 Product Offerings
24.6.4 Key Strategies
24.6.5 Key Strengths
24.6.6 Key Opportunities
24.7 Change Healthcare
24.7.1 Business Overview
24.7.2 Change Healthcare in Medical Imaging & Diagnostics Software Market
24.7.3 Product Offerings
24.7.4 Key Strategies
24.7.5 Key Strengths
24.7.6 Key Opportunities
24.8 Koninklijke Philips
24.8.1 Business Overview
24.8.2 Koninklijke Philips N.V. in Medical Imaging & Diagnostics Software Market
24.8.3 Product Offerings
24.8.4 Key Strategies
24.8.5 Key Strengths
24.8.6 Key Opportunities
24.9 Fujifilm
24.9.1 Business Overview
24.9.2 Fujifilm in Medical Imaging & Diagnostics Software Market
24.9.3 Product Offerings
24.9.4 Key Strategies
24.9.5 Key Strengths
24.9.6 Key Opportunities
24.10 Sectra
24.10.1 Business Overview
24.10.2 Sectra AB in Medical Imaging & Diagnostics Software Market
24.10.3 Product Offerings
24.10.4 Key Strategies
24.10.5 Key Strengths
24.10.6 Key Opportunities
24.11 Intelerad Medical Systems
24.11.1 Business Overview
24.11.2 Intelerad Medical Systems in Medical Imaging & Diagnostics Software Market
24.11.3 Product Offerings
24.11.4 Key Strategies
24.11.5 Key Strengths
24.11.6 Key Opportunities

25 Other Prominent Vendors
25.1 MIM Software
25.1.1 Business Overview
25.1.2 Product Offerings
25.2 Aquilab SAS
25.2.1 Business Overview
25.2.2 Product Offerings
25.3 Esaote SpA
25.3.1 Business Overview
25.3.2 Product Offerings
25.4 Canon Medical Systems USA
25.4.1 Business Overview
25.4.2 Product Offerings
25.5 Hitachi Healthcare Americas
25.5.1 Business Overview
25.5.2 Product Offerings
25.6 Spacelabs Healthcare
25.6.1 Business Overview
25.6.2 Product Offerings
25.7 Hologic
25.7.1 Business Overview
25.7.2 Product Offerings
25.8 Samsung Healthcare
25.8.1 Business Overview
25.8.2 Product Offerings
25.9 Lunit
25.9.1 Business Overview
25.9.2 Product Offerings
25.10 Arterys
25.10.1 Business Overview
25.10.2 Product Offerings
25.11 Gauss Surgical
25.11.1 Business Overview
25.11.2 Product Offerings
25.12 Zebra Medical Vision
25.12.1 Business Overview
25.12.2 Product Offerings
25.13 Caption Health
25.13.1 Business Overview
25.13.2 Product Offerings
25.14 RetinAI Medical
25.14.1 Business Overview
25.14.2 Product Offerings
25.15 Subtle Medical
25.15.1 Business Overview
25.15.2 Product Offerings
25.16 BrainMiner
25.16.1 Business Overview
25.16.2 Product Offerings
25.17 Bruker
25.17.1 Business Overview
25.17.2 Product Offerings
25.18 Xinapse Systems
25.18.1 Business Overview
25.18.2 Product Offerings
25.19 ClaroNav
25.19.1 Business Overview
25.19.2 Product Offerings
25.20 Pie Medical Imaging
25.20.1 Business Overview
25.20.2 Product Offerings
25.21 Analogic
25.21.1 Business Overview
25.21.2 Product Offerings
25.22 Konica Minolta
25.22.1 Business Overview
25.22.2 Product Offerings
25.23 Vieworks
25.23.1 Business Overview
25.23.2 Product Offerings
25.24 Mirada Medical
25.24.1 Business Overview
25.24.2 Product Offerings
25.25 Pro Medicus
25.25.1 Business Overview
25.25.2 Product Offerings
25.26 imeXHS
25.26.1 Business Overview
25.26.2 Product Offerings

26 Report Summary
26.1 Key Takeaways
26.2 Strategic Recommendations

27 Quantitative Summary
27.1 Market By Type
27.1.1 North America: Type Segmentation
27.1.2 Europe: Type Segmentation
27.1.3 APAC: Type Segmentation
27.1.4 Latin America: Type Segmentation
27.1.5 Middle East & Africa: Type Segmentation
27.2 Market By Modality
27.2.1 North America: Modality Segmentation
27.2.2 Europe: Modality Segmentation
27.2.3 APAC: Modality Segmentation
27.2.4 Latin America: Modality Segmentation
27.2.5 Middle East & Africa: Modality Segmentation
27.3 Market By Application
27.3.1 North America: Application Segmentation
27.3.2 Europe: Application Segmentation
27.3.3 APAC: Application Segmentation
27.3.4 Latin America: Application Segmentation
27.3.5 Middle East & Africa: Application Segmentation
27.4 Market By Imaging Type
27.4.1 North America: Imaging Type Segmentation
27.4.2 Europe: Imaging Type Segmentation
27.4.3 APAC: Imaging Type Segmentation
27.4.4 Latin America: Imaging Type Segmentation
27.4.5 Middle East & Africa: Imaging Type Segmentation
27.5 Market By End-User
27.5.1 North America: End-user Segmentation
27.5.2 Europe: End-user Segmentation
27.5.3 APAC: End-user Segmentation
27.5.4 Latin America: End-user Segmentation
27.5.5 Middle East & Africa: End-user Segmentation
27.6 Market By Geography
27.6.1 Medical Imaging Analysis Software: Geographical Segmentation
27.6.2 Medical Imaging Processing Software: Geographical Segmentation
27.6.3 Medical Imaging Management Software: Geographical Segmentation
27.6.4 Others: Geographical Segmentation
27.6.5 Ultrasound: Geographical Segmentation
27.6.6 Radiography: Geographical Segmentation
27.6.7 Computerized Tomography: Geographical Segmentation
27.6.8 Magnetic Resonance Imaging: Geographical Segmentation
27.6.9 Mammography: Geographical Segmentation
27.6.10 PET/SPECT: Geographical Segmentation
27.6.11 Others: Geographical Segmentation
27.6.12 Cardiology: Geographical Segmentation
27.6.13 Orthopedic: Geographical Segmentation
27.6.14 Oncology: Geographical Segmentation
27.6.15 Neurology: Geographical Segmentation
27.6.16 Gastroenterology: Geographical Segmentation
27.6.17 Dental: Geographical Segmentation
27.6.18 Obstetrics & Gynecology: Geographical Segmentation
27.6.19 Others: Geographical Segmentation
27.6.20 2D: Geographical Segmentation
27.6.21 3D: Geographical Segmentation
27.6.22 Others: Geographical Segmentation
27.6.23 Hospitals: Geographical Segmentation
27.6.24 Diagnostic Centers: Geographical Segmentation
27.6.25 Ambulatory Surgical Centers: Geographical Segmentation
27.6.26 Research & Academic Institutes: Geographical Segmentation

28 Appendix
28.1 Abbreviations



*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/



※注目の調査資料
※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
※当市場調査資料(ARZT21MY008 )"世界の医療用画像ソフトウェア市場2021年-2026年" (英文:Medical Imaging Software Market - Global Outlook and Forecast 2021-2026)はArizton Advisory & Intelligence社が調査・発行しており、H&Iグローバルリサーチが販売します。


◆H&Iグローバルリサーチのお客様(例)◆


※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。